Kahr Medical

Last updated: May 07, 2024

Yaron Pereg - CEO
Yaron Pereg - CEO
Israel | Funding: $101.5M (+)

Website: https://kahrbio.com/

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.